Industry Briefs

Beating The Japanese At Their Own Game You wouldn’t enter a fist fight with one hand tied behind your bad so why fight Japan’s technological prowess with the serious handicap of being thousands of miles away from the island nation A far better strategy, argues John R Stern, executive director of the U.S. Electronics Industry’s Japan office, is to set up shop in the Land of the Rising Sun. In a recent talk at the Industrial Biotechnology Association’s annual meeting, Ste

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

You wouldn’t enter a fist fight with one hand tied behind your bad so why fight Japan’s technological prowess with the serious handicap of being thousands of miles away from the island nation A far better strategy, argues John R Stern, executive director of the U.S. Electronics Industry’s Japan office, is to set up shop in the Land of the Rising Sun. In a recent talk at the Industrial Biotechnology Association’s annual meeting, Stern urged his audience to follow the example of some electronics firms and form subsidiaries abroad. The reason: In Japan, a foreign subsidiary can grow by “foraging,” explained Stem, “that is, by taking advantage of aspects of the foreign environment that are more favorable than at home.” One such perk is the money that the Japan Development Bank has made available to foreign-owned companies: Millions of dollars are set aside for long-term, fixed-rate loans for up to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies